NEW YORK, DECEMBER 31, 2022 (GLOBE NEWSWIRE) —
Why: Rosen Law Firm, a global investor rights law firm, is pleased to announce that, pursuant to our initial public offering (“IPO”), which will take place in September 2021, and/or traceable Olaplex Holdings, Inc. ( NASDAQ: OLPX) security to remind buyers. , of the material plaintiffs deadline of January 17, 2023.
SO WHAT: If you purchase Olaplex securities, you may be entitled to compensation without out-of-pocket fees or costs through performance fee arrangements.
What to do next: To join the Olaplex Class Action, please visit https://rosenlegal.com/submit-form/?case_id=10056 or call Esq. Phillip Kim. For class action information, please call toll-free 866-767-3653 or email firstname.lastname@example.org or email@example.com. A class action lawsuit has already been filed. If you want to act as lead plaintiff, you have until January 17, 2023 to challenge the court. A principal plaintiff is a representative party acting on behalf of other class members in the conduct of a lawsuit.
Why Rosen’s Law: Investors are encouraged to select qualified attorneys with a proven track record of success in leadership roles. Companies issuing notices often do not have comparable experience, resources, or meaningful peer recognition. Many of these law firms do not actually handle securities class action lawsuits, but are merely intermediaries that refer clients or are affiliated with the law firms that actually litigate. Choose your counselors wisely. Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivative actions. Rosen Law Firm Achieves Largest Securities Class Action Settlement Against Chinese Company Ever. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The company has ranked in his top four every year since 2013, and has collected hundreds of millions of dollars for its investors. In 2019 alone, the company secured more than $438 million of his for investors. In 2020, founding partner Lawrence Rosen was named a Giant of the Plaintiffs Bar Association by law360. Many of our attorneys are certified by Lawdragon and Super Lawyers.
Details of the lawsuit: The lawsuit alleges that the registration statement and prospectus used to effect Olaplex’s IPO either contained misstatements of material facts or were misleading. It omits statements of other facts necessary to make it legal and was not made according to the rules. Rules governing its preparation. Specifically, the offering documents made false and/or misleading statements and/or did not disclose: (2) Therefore, Olaplex is unlikely to maintain its sales and earnings momentum. (3) As a result, it is unlikely that Olaplex will be able to achieve the financial and operational growth anticipated in the offering document. (4) As a result, the application documents were materially false and/or misleading and did not contain the information required to be included therein.
To join the Olaplex Class Action, please visit https://rosenlegal.com/submit-form/?case_id=10056 or call Esq. Phillip Kim. For class action information, please call toll-free 866-767-3653 or email firstname.lastname@example.org or email@example.com.
There are no accredited classes. You will not be represented by an attorney unless you hold an attorney until your class is certified. You can choose your preferred contact point. You can also remain an absent class member and do nothing at this time. An investor’s ability to share in potential future recoveries is not dependent on serving as a primary plaintiff.
For the latest on LinkedIn, visit https://www.linkedin.com/company/the-rosen-law-firm and follow us on Twitter. https://twitter.com/rosen_firm Or Facebook: https://www.facebook.com/rosenlawfirm/.
Advertisement for lawyers. Previous results are no guarantee of similar results.
Lawrence Rosen, Esq.
Mr. Philip Kim
Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, New York 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
Copyright 2022 GlobeNewswire, Inc.